奎斯特诊断公司

出自 MBA智库百科(https://wiki.mbalib.com/)

本条目包含过多不是中文的内容，欢迎协助翻译。 若已有相当内容译为中文，可迳自去除本模板。

奎斯特诊断公司（Quest Diagnostics）

奎斯特诊断公司官方网站网址：http://www.questdiagnostics.com/ 英文

　　奎斯特诊断公司（Quest Diagnostics）是美国最大的临床诊断公司，也是是著名的生化医疗器材测试商。这家公司发起于1967年，期间经历多次并购，1996年在美国纽交所上市。Quest在美国拥有31个区域性大型诊断中心，155家快速反应实验室，超过2100个病人服务中心，每年诊断超过1亿个标本。

　　奎斯特诊断公司为健康护理专业人员提供专业知识，协助他们做出正确诊断，来改善病患的健康状况。这家公司透过所属的实验室和病患服务中心，为美国地区的民众提供诊断测试服务，并透过其人数众多的医疗和科学员工提供详尽的咨询服务。

　　目前，美国前三名公司的市场占有率超过60％，市场集中度很高。在欧美和日本等发达国家，独立实验室已经占据临床检验市场的1/3。而中国99％的检验业务仍在医院检验科完成。但相比Quest拥有的3000多项检验项目，中国的大型医院也只有500—1000个项目。2006年收入63亿美元。

　　Quest Diagnostics Incorporated (NYSE: DGX) is a United States corporation which provides clinical laboratory services. The company has operations in the United States, United Kingdom, Mexico and through its wholly-owned subsidiary Quest Diagnostics India Pvt. Ltd, a laboratory in India^[1] in addition to service locations located in Brazil. Quest Diagnostics also has collaborative agreements internationally with various hospitals and clinics.^[2] Quest Diagnostics also has operations in the US Territory of Puerto Rico.^[3]

　　Quest Diagnostics is a member of the Fortune 500 and the S&P 500. The company's corporate headquarters were previously located in Teterboro, New Jersey where the largest business unit is located. Currently, the corporate headquarters are located in Madison, New Jersey^[4] having moved there in October 2007 from Lyndhurst, New Jersey.

• 1967: Founded by Paul A. Brown, MD as Metropolitan Pathology Laboratory, Inc., in New York.
• 1969: Name Changed to MetPath, Inc., in Teaneck, New Jersey.
• 1982: MetPath was acquired by what was then known as Corning Glass Works, and subsequently renamed Corning Clinical Laboratories.
• 1997: Quest Diagnostics becomes an independent company as a spin-off from Corning.
• 1997: Acquires clinical laboratory division of Branford, CT-based Diagnostic Medical Laboratory, Inc. (DML)^[5].
• 1999: Acquires SmithKline Beecham Clinical Laboratories; GlaxoSmithKline still holds a large portion of Quest Diagnostics stock. The SmithKline Beecham acquisition includes a joint venture ownership with CompuNet Clinical Laboratory
• 2000: Launch of Six Sigma program leading the charge to raise the quality of healthcare delivery in the United States.
• 2001: Completes acquisition of Ohio-based MedPlus, Inc. (NASDAQ: MEDP), a healthcare technology company.
• 2002: Completes acquisition of Virginia-based American Medical Laboratories, Inc. (AML) and an affiliated company of AML, LabPortal, Inc., for approximately $500 million in cash.
• 2003: Completes acquisition of California-based Unilab Corporation (NASDAQ: ULAB) in a transaction valued at approximately $800 million .
• 2005: Completes acquisition of Kansas-based LabOne, Inc. (NASDAQ: LABS) for approximately $934 million.
• 2006: Completes acquisition of Virginia-based Focus Diagnostics, Inc., an infectious and immunologic disease laboratory, for approximately $185 million in cash.
• 2007: Quest Diagnostics celebrates its 10th year after being spun off from Corning.
• 2007: Completes acquisition of Sweden-based Hemocue, a point-of-care diagnostic testing company.
• 2007: Acquires AmeriPath, becoming the leading provider of cancer diagnostic testing services.
• 2010: Laid off 70 percent of processor's in Lenexa and have cut costs and employee overtime due to decline of clients, poor sales and poor managment.